Instil Bio Inc expected to post a loss of 16 cents a share - Earnings Preview

Instil Bio

08/08/2023 12:53

* Instil Bio Inc  TIL.OQ   TIL.O  is expected to show no
change in
quarterly revenue when it reports  results on August 10
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Instil Bio Inc is
for a
loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$5​, above​ its last closing price of $0.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.15       -0.15      -0.44     Missed  -183.9
 Dec. 31 2023  -0.40       -0.41      -0.24     Beat    41.9
 Sep. 30 2022  -0.45       -0.44      -0.43     Beat    1.4​
 Jun. 30 2022  -0.38       -0.41      -0.46     Missed  -11.7
 ​​Mar.        -0.38       -0.38      -0.42     Missed  -9.6
 31 2022                                                
 Dec. 31 2021  -0.36       -0.36      -0.43     Missed  -18.6​
 Sep. 30 2021  -0.32       -0.32      -0.33     Missed  -1.9
 Jun. 30 2021  -0.21       -0.20      -0.27     Missed  -31.7
 This summary was machine generated August 8 at 11:53 GMT.  All
figures in US dollars  unless otherwise stated